Windlas Biotech Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Windlas Biotech Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
quick-summary-circle
WINDLAS

Click to see a quick summary and important updates about this stock!Dismiss

Windlas Biotech Ltd.

BSE: 543329, NSE: WINDLAS

  • Market Capitalisation market-capitalisation-info ₹507 Cr
  • 12 Month Earnings monthly-earning ₹46 Cr
  • Price to Earnings price-to-earning 11.04

₹240.10

As on 23-Mar-2023 09:44 IST

up-down-arrow ₹-1.05 • -0.44%

  • Prev Close info

    ₹241.15

  • Day's Openinfo

    ₹241.05

  • Today's Highinfo

    ₹241.35

  • Today's Lowinfo

    ₹239.70

  • Today's Volumeinfo

    1,816

Stock Performance
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Windlas Biotech
-4.00 -3.19 -1.92 2.48 -- -- --
S&P BSE Healthcare
-5.97 -1.49 -8.01 -10.35 21.78 10.24 10.54
S&P BSE Small Cap
-5.89 -1.41 -4.22 -2.27 39.10 9.79 16.78
As on 23-Mar-2023
2022
Windlas Biotech
-9.37
S&P BSE Small Cap
-1.80
S&P BSE Healthcare
-12.10

Valuation
Stock
Peer Median

Growth & Efficiency
Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

View Details arrow

Peer Comparison

search
search
search
search
    Comparison Details arrow

    Valuation Chart of Windlas Biotech Ltd.

        Financials

        View Details arrow

        Shareholding Pattern

        View Details arrow

        News & Analysis of Windlas Biotech Ltd.

        sigachi-industries-ipo-information-analysis

        Sigachi Industries IPO: Information analysis

        By Arul Selvan and Udhayaprakash

        ipo-update-windlas-biotech

        IPO update: Windlas Biotech

        By Udhayaprakash

        windlas-biotech-ipo-analysis

        Windlas Biotech: IPO analysis

        By Arul Selvan

        All News arrow

        Incorporated

        2001

        Chairman

        Vivek Dhariwal

        Managing Director

        Hitesh Windlass

        Headquarters

        Dehradun, Uttarakhand

        Website

        www.windlasbiotech.com
        More Details arrow
        Edit peer-selector-edit

        Key Facts

        • Market cap market-cap-information ₹507.46 Cr
        • Revenue (TTM)revenue-information ₹494.50 Cr
        • Earnings (TTM) earning-information ₹45.97 Cr
        • Cash date-information ₹179.42 Cr
        • Total Debt info ₹6.12 Cr
        • Promoters' ownership promoters_ownership 60.75%
        • Liquidity liquidity High
        • 52 Week range week-range ₹203.25 - 284.00
        • Face value face-value ₹5.00
        • Shares outstanding share-outstanding 2,10,43,519
        • 10 Years Aggregate:

          CFO: ₹102.68 Cr

          EBITDA: ₹337.62 Cr

          Net Profit: ₹195.95 Cr

        About The Company

        • Business Manufacture of pharmaceuticals, medicinal chemical and botanical products
        • Incorporated 2001
        • Chairman Vivek Dhariwal
        • Managing Director Hitesh Windlass
        • Listing key-listing BSE: 543329, NSE: WINDLAS
        • Country India
        • Headquarters headquarters Dehradun, Uttarakhand
        • Website website www.windlasbiotech.com
        Add Portfolio by-stock Add to watchlist watchlist-stock-modal Share Download Stock Report
        Portfolio stock-portfolio Watchlist watchlist-stock-modal share-fund-icon Download Stock Report
        Portfolio stock-investment Watchlist add-watchlist-icon share-fund-plan-icon